Cencora, Inc. (COR) key performance indicators and operating metrics (13 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Operating income (Adjusted, non-GAAP) | 1.3B | FY2026-Q2 |
| International Healthcare Solutions revenue | 7.6B | FY2026-Q2 |
| U.S. healthcare solutions revenue | 68.8B | FY2026-Q2 |
| Operating Margin (Adjusted non-GAAP) | 1.61 percent | FY2026-Q2 |
| AmerisourceBergen Diluted earnings per share (Adjusted non-GAAP) | 4.75 USD_per_share | FY2026-Q2 |
| Effective tax rate (Adjusted, non-GAAP) | 18.90 percent | FY2026-Q2 |
| Effective tax rate (GAAP) | 22.00 percent | FY2026-Q2 |
| Gross Margin (Adjusted non-GAAP) | 4.31 percent | FY2026-Q2 |
| Gross Profit (Adjusted non-GAAP) | 3.4B | FY2026-Q2 |
| Revenue growth y/y | 5.50 percent | FY2026-Q1 |
| Revenue (Total) | 85.9B | FY2026-Q1 |
| Net Interest Expense | 72.2M | FY2026-Q1 |
| Adjusted diluted EPS growth y/y | 9.40 percent | FY2026-Q1 |
Back to COR overview · COR earnings · COR holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.